Related references
Note: Only part of the references are listed.Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice
Cyrille Vaillend et al.
HUMAN MOLECULAR GENETICS (2017)
Reduced serum myostatin concentrations associated with genetic muscle disease progression
Peter M. Burch et al.
JOURNAL OF NEUROLOGY (2017)
Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy
Gourav Bhardwaj et al.
JOURNAL OF PROTEOMICS (2017)
Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy
Sandra Murphy et al.
JOURNAL OF PROTEOMICS (2016)
Periostin expression induced by oxidative stress contributes to myocardial fibrosis in a rat model of high salt-induced hypertension
Han Wu et al.
MOLECULAR MEDICINE REPORTS (2016)
Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy
Thomas Froehlich et al.
SCIENTIFIC REPORTS (2016)
Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urine
Nobuhiro Maruyama et al.
SCIENTIFIC REPORTS (2016)
A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90
Christopher N. J. Young et al.
AUTOPHAGY (2015)
Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype
Natassia M. Vieira et al.
CELL (2015)
Protein amino-terminal modifications and proteomic approaches for N-terminal profiling
Zon W. Lai et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2015)
Single muscle fiber proteomics reveals unexpected mitochondrial specialization
Marta Murgia et al.
EMBO REPORTS (2015)
Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration
Thomas C. Roberts et al.
HUMAN MOLECULAR GENETICS (2015)
GRP78/BiP/HSPA5/Dna K is a Universal Therapeutic Target for Human Disease
Laurence Booth et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Duchenne Muscular Dystrophy: From Diagnosis to Therapy
Maria Sofia Falzarano et al.
MOLECULES (2015)
204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands
Alessandra Ferlini et al.
NEUROMUSCULAR DISORDERS (2015)
European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene
Manuel Haas et al.
NEUROMUSCULAR DISORDERS (2015)
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
Yetrib Hathout et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis
Ashling Holland et al.
PROTEOMICS (2015)
Label-free mass spectrometric analysis reveals complex changes in the brain proteome from the mdx-4cv mouse model of Duchenne muscular dystrophy
Sandra Murphy et al.
CLINICAL PROTEOMICS (2015)
Perilipin 4 in human skeletal muscle: localization and effect of physical activity
Shirin Pourteymour et al.
PHYSIOLOGICAL REPORTS (2015)
Myopathy in Marinesco-Sjogren syndrome links endoplasmic reticulum chaperone dysfunction to nuclear envelope pathology
Andreas Roos et al.
ACTA NEUROPATHOLOGICA (2014)
Dystrophin complex functions as a scaffold for signalling proteins
Bruno Constantin
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies
Burcu Ayoglu et al.
EMBO MOLECULAR MEDICINE (2014)
Caspase-12 ablation preserves muscle function in the mdx mouse
Catherine Moorwood et al.
HUMAN MOLECULAR GENETICS (2014)
Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy
Jeremy Rouillon et al.
NEUROMUSCULAR DISORDERS (2014)
Dysfunctional Muscle and Liver Glycogen Metabolism in mdx Dystrophic Mice
David I. Stapleton et al.
PLOS ONE (2014)
Defects in Mitochondrial ATP Synthesis in Dystrophin-Deficient Mdx Skeletal Muscles May Be Caused by Complex I Insufficiency
Emma Rybalka et al.
PLOS ONE (2014)
Fibronectin is a serum biomarker for Duchenne muscular dystrophy
F. Cynthia Martin et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
HKH40A downregulates GRP78/BiP expression in cancer cells
T. Kosakowska-Cholody et al.
CELL DEATH & DISEASE (2014)
Rescue of dystrophic skeletal muscle by PGC-1α involves restored expression of dystrophin-associated protein complex components and satellite cell signaling
Katrin Hollinger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion
Stephanie Duguez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: involvement of GRP78
Mehdi Hammadi et al.
FASEB JOURNAL (2013)
Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle
Nikolai Klymiuk et al.
HUMAN MOLECULAR GENETICS (2013)
Novel Highly Sensitive, Specific, and Straightforward Strategy for Comprehensive N-Terminal Proteomics Reveals Unknown Substrates of the Mitochondrial Peptidase Icp55
A. Saskia Venne et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Identification of Disease Specific Pathways Using in Vivo SILAC Proteomics in Dystrophin Deficient mdx Mouse
Sree Rayavarapu et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
The cooperative international neuromuscular research group duchenne natural history studya longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used
Craig M. McDonald et al.
MUSCLE & NERVE (2013)
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
Rebecca J. Fairclough et al.
NATURE REVIEWS GENETICS (2013)
Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of Dystrophy
Cintia Yuri Matsumura et al.
PLOS ONE (2013)
Repositioning of Verrucosidin, a Purported Inhibitor of Chaperone Protein GRP78, as an Inhibitor of Mitochondrial Electron Transport Chain Complex I
Simmy Thomas et al.
PLOS ONE (2013)
Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin
Ashling Holland et al.
PROTEOMICS (2013)
Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy
Laurence Viollet et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Evidence-Based Path to Newborn Screening for Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2012)
Perilipin family members preferentially sequester to either triacylglycerol-specific or cholesteryl-ester-specific intracellular lipid storage droplets
Kai Hsieh et al.
JOURNAL OF CELL SCIENCE (2012)
Rescue of Dystrophic Skeletal Muscle by PGC-1α Involves a Fast to Slow Fiber Type Shift in the mdx Mouse
Joshua T. Selsby et al.
PLOS ONE (2012)
The diverse functions of GAPDH: Views from different subcellular compartments
Carlos Tristan et al.
CELLULAR SIGNALLING (2011)
Quantitative Proteomic Analysis of Dystrophic Dog Muscle
Laetitia Guevel et al.
JOURNAL OF PROTEOME RESEARCH (2011)
MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway
Davide Cacchiarelli et al.
CELL METABOLISM (2010)
Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78
Yasufumi Katanasaka et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Ringo: Discordance between the molecular and clinical manifestation in a Golden Retriever Muscular Dystrophy dog
Eder Zucconi et al.
NEUROMUSCULAR DISORDERS (2010)
Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78
Marina. S. Gorbatyuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Functions and pathologies of BiP and its interaction partners
J. Dudek et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Autoimmune Mechanisms Underlying Dilated Cardiomyopathy
Tsutornu Yoshikawa et al.
CIRCULATION JOURNAL (2009)
Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage
Hao-Ven Wang et al.
JOURNAL OF CELL BIOLOGY (2008)
Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength
C. E. Ambrosio et al.
NEUROMUSCULAR DISORDERS (2008)
Pathophysiology of duchenne muscular dystrophy: Current hypotheses
Nicolas Deconinck et al.
PEDIATRIC NEUROLOGY (2007)
Immunoadsorption in dilated cardiomyopathy:: 6-month results from a randomized study
Alexander Staudt et al.
AMERICAN HEART JOURNAL (2006)
The evolution of iron chelators for the treatment of iron overload disease and cancer
DS Kalinowski et al.
PHARMACOLOGICAL REVIEWS (2005)
Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy - Long-term effect
B Balaban et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2005)
Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1α, drives utrophin gene expression at the neuromuscular junction
LM Angus et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Metabolic control through the PGC-1 family of transcription coactivators
JD Lin et al.
CELL METABOLISM (2005)
Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy
F Knebel et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2004)
Increased expression of glial fibrillary acidic protein in the brain of spontaneously hypertensive rats
D Tomassoni et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2004)
Adipocyte protein S3-12 coats nascent lipid droplets
NE Wolins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The dystrophin lymphocyte promoter revisited: 4.5-megabase intron, or artefact?
JM Wheway et al.
NEUROMUSCULAR DISORDERS (2003)
The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy
FLM Norwood et al.
STRUCTURE (2000)
Share Paper
